Top 7 Equine Systemic Medications for Pain & Infection in Canada (2025): Expert-Approved Options, Safe Dosing and Stewardship Guidance

Equioxx Oral Paste (firocoxib) is a leader among equine COX-2 selective NSAID pastes, offering precise, labeled dosing and a safety profile designed to reduce gastrointestinal complications versus older nonselective agents, which makes it a strong option for vet-directed first-aid management of lameness or acute inflammation. Technically similar to Previcox in active ingredient and clinical intent, Equioxx’s equine-specific labeling and ease-of-use paste format give it a market advantage for on-site, rapid administration despite higher cost per dose than phenylbutazone powder or OTC pellet options. For first-aid protocols that prioritize controlled dosing and GI safety over upfront cost, Equioxx is often chosen ahead of nonselective or herbal alternatives.

Metacam (meloxicam) is positioned as the safer COX‑2 preferential injectable option for equine first‑aid, offering solid anti‑inflammatory and analgesic effects with a relatively lower risk of gastrointestinal and renal adverse events compared with non‑selective NSAIDs like flunixin or phenylbutazone. Financially it tends to be higher priced per dose than older generics but can reduce downstream complication costs in fragile or repeatedly treated patients; technically it is a preferred first‑aid choice for soft‑tissue or musculoskeletal injuries where safety for follow‑up dosing is a priority. Compared to Banamine and flunixin generics it sacrifices some visceral analgesia for a better safety margin, making it complementary rather than a direct replacement.

Excenel RTU EZ is a ready-to-use ceftiofur formulation favored in equine practice for reliable beta-lactam broad-spectrum coverage and the convenience of a pre-mixed injectable. It earns a best-in-class position for combining strong activity against common equine pathogens with reduced preparation time and lower waste compared with multi-component generics, though its acquisition cost is typically higher than basic tetracyclines.

A widely used, cost-efficient systemic glucocorticoid for equine first-aid, dexamethasone holds a leading position because of its high potency, predictable dose-response and broad availability for field use. Compared with Prednisolone and hydrocortisone preparations it delivers longer anti‑inflammatory coverage per dose and is generally less expensive than some long‑acting depot options like Depo‑Medrol, making it the practical first-line choice for acute, short‑to‑medium duration control of inflammation in first‑aid settings.

Torbugesic is a butorphanol tartrate formulation commonly used in equine first aid for its rapid onset and combined analgesic-sedative effects; as a kappa agonist/mu antagonist it typically produces less respiratory depression than full mu agonists, improving safety in the field. Compared with the other products on this list, Torbugesic offers a cost-effective, readily available short‑duration option for rescue analgesia, though it delivers less potent and shorter-lasting pain control than full mu agonists such as morphine or hydromorphone.

Dexdomitor Injectable (dexmedetomidine) holds a technical edge as a highly alpha‑2 selective sedative providing potent, predictable sedation and analgesia with a favorable reversibility profile, which can be especially valuable in controlled first‑aid interventions. While typically priced higher than medetomidine or generic agents, its potency and dose predictability reduce volume and handling variability, an advantage when precise, short‑duration sedation is required in the field.